Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2019

Oct 3, 2019

34129_dirs_2019-10-03_74e799e4-8513-4b50-b085-205cb8375f38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-09-27

Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-27 Common Stock M 1662 $0.94 Acquired 32468 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-27 Stock Option (right to buy) $0.94 M 1662 Disposed 2020-01-09 Common Stock (1662.0) Direct

Footnotes

F1: The transaction represents an exercise and hold of expiring options.